Skip to content

I-gel Plus Supraglottic Airway Device for Elective Laparoscopic Surgery

I-gel Plus Supraglottic Airway Device for Elective Laparoscopic Surgery -a Prospective Observational Study-

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06602830
Enrollment
48
Registered
2024-09-19
Start date
2024-10-01
Completion date
2025-02-03
Last updated
2025-06-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Airway Management, General Anesthesia, Laparoscopic Surgery, Supraglottic Airway

Keywords

Airwaymanagement, Laparoscopic surgery, Capnoperitoneum

Brief summary

i-gel Plus is a novel supraglottic airway device (SGA). Feasibility of second-generation SGAs in patients undergoing elective laparoscopic surgery has been demonstrated in various studies. During laparoscopic surgery intrabdominal pressure is increased by capnoperitoneum and frequently minute ventilation has to be adopted to counteract hypercapnia, and higher inspiratory peak pressures have to be expected. It is uncertain, however, if the i-gel Plus facilitates appropriate ventilation with low leakage volumes in patients undergoing laparoscopic surgery. The primary aim of this single-center non-inferiority study is to assess the leak fraction of the i-gel Plus under conditions of capnoperitoneum (with and without Trendelenburg position) and to compare it with baseline conditions. Secondary aims are to assess secondary outcome parameters during capnoperitoneum (with and without Trendelenburg position) and to compare them with baseline conditions.

Interventions

None listed

Sponsors

Universitätsklinikum Hamburg-Eppendorf
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 89 Years
Healthy volunteers
No

Inclusion criteria

* Patients scheduling for elective laparoscopic surgery * Planned airway management using a SGA * Adult patients (age 18-89 years) * ASA physical status 1-3

Exclusion criteria

* Pregnant or breastfeeding women * Non-fasted patients * Increased risk of aspiration or other contraindications for supraglottic mask ventilation * Body mass index (BMI) \>35 kg/m2 * Inability to understand or sign informed consent

Design outcomes

Primary

MeasureTime frameDescription
Leak fraction3 houresVentilation parameter - volume per tidal volume

Secondary

MeasureTime frameDescription
Leakage volume (ml)3 houresVentilation parameter - as displayed on the ventilator
Tidal volume (ml)3 houresVentilation parameter - as displayed on the ventilator
Inspiratory peak pressure (cm H2O)3 houresVentilation parameter - as displayed on the ventilator
Positive endexpiratory pressure (PEEP) (cm H2O)3 houresVentilation parameter - as displayed on the ventilator
Intraabdominal pressure under capnoperitoneum [mmHg]3 houresMeasured intraoperativ under capnoperitoneum \[mmHg\]
Respiratory rate (1/min)3 houresVentilation parameter - as displayed on the ventilator
Minute ventilation (l/min/kg)3 houresVentilation parameter - as displayed on the ventilator
Endtidal CO2 [mmHg]3 houresVentilation parameter - as displayed on the ventilator
Number of insertion attempts3 houresClinical assessment - SGA insertion attempts
Oropharyngeal seal pressure [cm H2O]3 houresClinical assessment - leak pressure with audible leak
First-attempt insertion success rate (%)3 houresClinical assessment - successful placement in only one insertion attempt
Necessity of adjustment maneuvers during the procedure3 houresClinical assessment
Insertion time (sec)3 houresClinical assessment
Lowest oxygen saturation (%)3 houresMeasured by pulse oximetry
Difficulty of insertion3 houresClinical assessment on a scale between 1-5
Ease of gastric tube insertion3 houresClinical assessment - rating on a scale from 1-5
Postoperative complications24 hours postoperativelyClinical assessment
Complications at the end of surgery3 hoursClinical assessment
Insertion success rate (%)3 houresClinical assessment

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026